Abstract
Telomeres are specialized nucleoproteins that have an important role in chromosome structure and function (1). The telomeric DNA together with it’s associated proteins protects the chromosome ends from degredation or aberrant recombination (1,2). In most eukaryotes telomeric DNA consists of tracts of simple, tandemly repeated sequences running 5′ to 3′ toward the distal ends of the chromosome. In humans the sequence TAGGG is repeated hundreds of thousands of times (3–7) but there can be large variations in the number of telomeric repeats between organisms; i.e., in ciliates there can be fewer than 50 nucleotides of repeated DNA, whereas some mouse strains have more than 100 kilobase (kb) repeats (1,8). Mammals show tissue-to-tissue variation in average telomere length (6,7,9–11 and within a single mammalian cell, length of telomeres varies between different chromosomes (12,13)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blackburn, E. H. (1991) Structure and function of telomeres. Nature 350, 569–573.
Zakian, V. A. (1989) Structure and function of telomeres. Annu. Rev. Genet. 23, 579–604.
Moyzis, R. K., Buckingham, J. M., Cram, L. S., et al. (1988) A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA 85, 6622–6626.
Brown, W. R. A. (1989) Molecular cloning of human telomeres in yeast. Nature 338, 774–776.
Cross, S. H., Allshire, R. C., McKay, S. J., McGill, N. I. and Cooke, H. J. (1989) Cloning of human telomeres by complementation in yeast. Nature 338, 771–774.
de Lange, T., Shiue, L., Myers, R. M.,et al. (1990) Structure and variability of human chromosome ends. Mol. Cell Biol. 10, 518–527.
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., and Allshire, R. C. (1990) Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866–868.
Henderson, E. (1995) in Telomeres. (Blackburn, E. H., and Greider, C. W., eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 11–34.
Cooke, H. J. and Smith, B. A. (1986) Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harbor Symp. Quant. Biol. 51, 213–219.
Prowse, K. R. and Greider, C. W. (1995) Developmental and tissue specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92, 4818–4822.
Allshire, R. C., Dempster, M., and Hastie, N. D. (1989) Human telomeres contain at least three types of G-rich repeats distributed non-randomly. Nucleic Acids Res. 17, 4611–4627
Lansdorp, P. M., Verwoerd, N. P., van de Rijke, F. M., et al. (1996) Heterogeneity in telomere length of human chromosomes. Hum. Mol. Genet. 5, 685–691.
Henderson, S., Allsopp, R., Spector, D., Wang, S. S., and Harley, C. (1996) In situ analysis of changes in telomere size during relicative ageing and cell transformation. J. Biol. Chem. 134, 1–12.
Buchkovich, K. J. and Greider, C. W. (1996) Telomerase regulation during entry into the cell cycle in normal human T cells. Mol. Biol. Cell 134, 1443–1454
Nakamura, T. M. and Cech, T. R. (1998) Reversing time: origin of telomerase. Cell 92, 587–590.
Weng, N. P., Levine, B. L., June, C. H., and Hodes, R. J. (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183, 2471–2479.
Holt SE, Wright WE and Shay JW (1996). Regulation of telomerase activity in immortal cell lines. Mol. Cell Biol. 16, 2932–2939.
Shay, J. W. (1998) Telomerase in cancer: diagnostic, prognostic and therapeutic implications. Cancer J. Sci. Am. 4, S1, S26–S34.
Achi, M.V., Ravindranath, N., and Dym, M. (2000) Telomere length in male germ cells is inversely correlated with telomerase activity. Biol. Reprod., 63, 591–598.
Weinrich, S. L., Pruzan, R., Ma, L., et al. (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17, 498–502.
Greider, C. W. and Blackburn, E. H. (1985) Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 43, 405–413.
Shippen-Lentz, D. and Blackburn, E. H. (1990) Functional evidence for an RNA template in telomerase. Science 269, 546–552.
Blasco, M. A., Funk, W., Villeponteau, B., and Greider, C. W. (1995) Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267–1270.
Feng, J., Funk, W. D., Wang, S. S., et al. (1995) The RNA component of human telomerase. Science 269, 1236–1241.
Nakamura, T. M., Morin, G. B., Chapman, K. B., et al. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955–959.
Soder, A. I., Hoare, S. R., Muir, S., Going, J. J., Parkinson, E. K. and Keith, W. N (1997) Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 14, 1013–1021.
Soder, A. I., Hoare, S. F., Muire, S., et al. (1997) Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting. Genomics 41, 293–294.
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., and Cech, T. R. (1997) Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276, 561–567.
Meyerson, M., Counter, C. M., Eaton, E. N., et al. (1997) hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 90, 785–795.
Killian, A., Bowtell, D. D. L., Abud, H. E., et al. (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6, 2011–2019.
Harrington, L., McPhail, T., Mar, V., et al. (1997) A mammalian telomerase associated protein. Science 275, 973–977.
Zhao, J.-Q., Hoare, S. F., McFarlane, R., et al. (1998) Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene 16, 1345–1350.
Bachand, F. and Autexier, C. (2001) Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions. Mol. Cell. Biol. 21, 1888–1897.
Yi, X. M., White, D. M., Aisner, D. L., Baur, J. A., Wright, W. E., and Shay, J. W. (2000) An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia, 2, 433–440.
Koyanagi, Y., Kobayashi, D., Yajima, T., et al. (2000) Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells. Anticancer Res. 20, 773–778.
Krams, M., Claviez, A., Klapper, W., Tiemann, M., and Parwaresch, R. (2000) Upregulated telomerase activity and high mRNA levels of the catalytic telomerase subunit hTERT in Hodgkin and Reed Sternberg cells. Blood 96, 3142.
Ouellette, M. M., Aisner, D. L., Savre-Train, I., Wright, W. E., and Shay, J. W. (1999) Telomerase activity does not always imply telom-ere maintenance. Biochem. Biophys. Res. Commun. 254, 795–803.
Yokoyama, Y., Takahashi, Y., Shinohara, A., et al. (2000) The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. Biochem. Biophys. Res. Commun. 273, 316–321.
Harley, C. B. (1991) Telomere loss: mitotic clock or genetic time bomb? Mutat. Res. 256, 271–282.
Avilion, A. A., Harrington, L. A., and Greider, C. W. (1992) Tetrahy-mena telomerase RNA levels increase during macronuclear development. Dev. Genet. 13, 80–86.
Price, C. M., Adams, A. K., and Vermeesch, J. R. (1994) Accumulation of telomerase RNA and telomere protein transcripts during telomere synthesis in Euplotes. J. Eukaryot. Microbiol. 41, 267–275.
Villeponteau, B. (1996) The RNA components of human mouse telomerases. Cell Dev. Biol. 7, 15–21.
Bryan, T. M., Marusic, L., Bacchetti, S., Namba, M., and Reddel, R. R. (1997) The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet. 6, 921–926.
Blasco, M., Lee, H-W., Hande, M., et al. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34.
Lee, H-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., and DePinho, R. A. (1998). Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569–574.
Bodnar, A. G., Ouellette, M., Frolkis, M., et al. (1998) Extension of life-span by introduction of telomerase into normal cells. Science 279, 349–352.
Bacchetti, S. (1996) Telomere dynamics and telomerase activity in cell senescence and cancer. Cell Dev. Biol. 7, 31–39.
Shay, J. W. and Bacchetti, S. (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787–791.
Kim, N. W., Piatyszek, M. A., Prowse, K. R., et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2014.
Ballon, G., Trentin, L., de Rossi, A., and Semenzato, G. (2001) Telomerase activity and clinical progression in chronic lymphoproliferative disorders of B-cell lineage. Leuk. Lymphoma 41, 35.
Bialkowska-Hobrzanska, H., Bowles, L., Bukala, B., Joseph, M. G., Fletcher, R., and Razvi, H. (2000) Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma. Mol. Diagnosis 5, 267–277.
Chang, J. T. C., Liao, C. T., Jung, S. M., Wang, T. C. V., See, L. C., and Cheng, A. J. (2000) Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues. Br. J. Cancer 82, 1946–1951.
Choi, L. M. R., Kim, N. W., Zuo, J. J., et al. (2000) Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma. Med. Pediatr. Oncol. 35, 647–650.
Hiyama, E., Saeki, T., Hiyama, K., et al. (2000) Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples. Cancer Cytopathol. 90, 235–238.
Poremba, C., Willenbring, H., Hero, B., et al. (1999) Telomerase activity distinguishes between neuroblastomas with good and poor prognosis. Ann. Oncol. 10, 715–721.
Uchida, N., Otsuka, T., Arima, F., et al. (1999) Correlation of telomerase activity with development and progression of adult T-cell leukemia. Leuk. Res. 23, 311–316.
Usselmann, B., Newbold, M., Morris, A., and Nwokolo, C. U. (2001) High tumor telomerase activity correlates with shortened patient survival and more advanced tumor stage in gastric but not in oesoph-ageal adenocarcinoma. Gut 48, 176.
Yan, P., Coindre, J. M., Benhattar, J., Bosman, F. T., and Guillou, L. (1999) Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: Correlation with grade, histology, and proliferative activity. Cancer Res. 59, 3166–3170.
Yoo, J. and Robinson, R. A. (2000). Expression of telomerase activity and telomerase RNA in human soft tissue sarcomas. Arch. Pathol. Lab. Med. 124, 393–397.
Yoshida, R., Kiyozuka, Y., Ichiyoshi, H., et al. (1999) Change in telomerase activity during human colorectal carcinogenesis. Antican-cerRes. 19, 2167–2172
Bamberger, C. M., Else, T., Bamberger, A. M., et al. (1999) Telomerase activity in benign and malignant adrenal tumors. Exper. Clin. Endocrinol. Diabetes 107, 272–275.
Arai, Y., Yajima, T., Yagihashi, A., et al. (2000) Limitations of urinary telomerase activity measurement in urothelial cancer. Clin. Chim.Acta 296, 35–44.
Shroyer, K. R., Thompson, L. C., Enomoto, T., Eskens, J. L., Shroyer, A. L., and McGregor, J. A. (1998) Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia and squamous cell carcinoma of the uterine cervix. Am. J.Clin. Pathol. 109, 153–162.
Yokoyama, Y., Takahashi, Y., Shinohara, A., Lian, Z., and Tamaya, T. (1998) Telomerase activity in the female reproductive tract and neoplasms. Gynecol. Oncol. 68, 145–149.
Mayfield, M. P., Shah, T., Flannigan, G. M., Stewart, P. A. H., and Bibby, M. C. (1998) Telomerase activity in malignant and benign bladder conditions. Int. J. Mol. Med. 1, 835–840.
Kim, N. W. (1997) Clinical implications of telomerase in cancer. Eur. J. Cancer 33, 781–786.
Carey, L. A., Kim, N. W., Goodman, S., et al. (1999) Telomerase activity and prognosis in primary breast cancers. J. Clin. Oncol. 17, 3075–3081.
Bitisik, O., Yavuz, S., Yasasever, V., and Dalay, N. (2000) Telomerase activity in patients with chronic myeloid leukemia and lymphoma. Res. Commun. Mol. Pathol. Pharmacol. 107, 3–12.
Holt, S.E., Shay, J. W., and Wright, W. E. (1996) Refining the telom-ere-telomerase hypothesis of ageing and cancer. Nat. Biotechnol. 14, 836–839.
Breslow, R. A., Shay, J. W., Gazdar, A. F., and Srivastava, S. (1997) Telomerase and early detection of cancer: a National Cancer Institute Workshop. J. Natl. Cancer Inst. 89, 618–623.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Bibby, M.C. (2002). Introduction to Telomeres and Telomerase. In: Double, J.A., Thompson, M.J. (eds) Telomeres and Telomerase. Methods in Molecular Biology™, vol 191. Humana Press. https://doi.org/10.1385/1-59259-189-2:01
Download citation
DOI: https://doi.org/10.1385/1-59259-189-2:01
Publisher Name: Humana Press
Print ISBN: 978-0-89603-657-4
Online ISBN: 978-1-59259-189-3
eBook Packages: Springer Protocols